From July 1, 2025, all pharmaceutical manufacturers must have established an alternative method to check all their products for pyrogens. The monocyte activation test (MAT) is always recommended, as it detects all types of pyrogens (both endotoxin and non-endotoxin pyrogens).
Our NAT-MAT® goes a little further in this respect, as it combines the classic MAT with nucleic acid amplification technology.
|
